1.78

1.71% +0.03

After Hours: 1.80 0.02 +1.12%

Tilray Brands Inc (TLRY)

Overview News Price History Option Chain Why TLRY Down? Discussions Forecast Stock Split

Tilray Brands Inc stock is currently priced at $1.78, with a 24-hour trading volume of 20.28M. It has seen a +1.71% increased in the last 24 hours and a -22.94% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $1.76 pivot point. If it approaches the $1.79 resistance level, significant changes may occur.

Previous Close:

$1.75

Open:

$1.77

24h Volume:

20.28M

Market Cap:

$1.38B

Revenue:

$743.25M

Net Income/Loss:

$-351.95M

P/E Ratio:

-0.7876

EPS:

-2.26

Net Cash Flow:

$-49.96M

1W Performance:

+2.89%

1M Performance:

-22.94%

6M Performance:

+0.56%

1Y Performance:

-18.35%

1D Range:

$1.75

$1.85

52W Range:

$1.50

$3.40

Tilray Brands Inc Stock (TLRY) Company Profile

Name

Tilray Brands Inc

Sector

Healthcare (1191)

Industry

Drug Manufacturers - Specialty & Generic (4)

Phone

844-845-7291

Address

1100 Maughan Road, Nanaimo

Employee

241

Twitter

@tilray

Next Earnings Date

2024-04-09

Latest SEC Filings

TLRY's Discussions on Twitter

Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-02-22	Initiated	Bernstein	Mkt Perform
Jul-29-22	Downgrade	The Benchmark Company	Hold → Sell
Mar-04-22	Upgrade	Canaccord Genuity	Hold → Buy
Nov-18-21	Initiated	Barclays	Underweight
Nov-01-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jun-11-21	Downgrade	CIBC	Sector Outperform → Neutral
Jun-03-21	Upgrade	Cantor Fitzgerald	Neutral → Overweight
May-11-21	Resumed	Cowen	Outperform
May-07-21	Resumed	Jefferies	Buy
May-06-21	Initiated	Canaccord Genuity	Buy
Apr-28-21	Resumed	BofA Securities	Buy
Feb-18-21	Downgrade	Piper Sandler	Overweight → Neutral
Feb-18-21	Downgrade	The Benchmark Company	Buy → Hold
Nov-16-20	Downgrade	Jefferies	Hold → Underperform
Nov-11-20	Downgrade	Stifel	Hold → Sell
Oct-01-20	Reiterated	MKM Partners	Neutral
Sep-21-20	Upgrade	Jefferies	Underperform → Hold
May-12-20	Reiterated	The Benchmark Company	Buy
Apr-16-20	Downgrade	Jefferies	Hold → Underperform
Apr-09-20	Downgrade	Consumer Edge Research	Overweight → Equal Weight
Feb-24-20	Downgrade	Cowen	Outperform → Market Perform
Jan-13-20	Initiated	BofA/Merrill	Neutral
Nov-13-19	Reiterated	The Benchmark Company	Buy
Nov-05-19	Initiated	Cantor Fitzgerald	Neutral
Oct-22-19	Reiterated	Piper Jaffray	Overweight
Sep-20-19	Initiated	MKM Partners	Neutral
Aug-14-19	Reiterated	The Benchmark Company	Buy
Jul-17-19	Initiated	Ladenburg Thalmann	Neutral
Jun-28-19	Initiated	Consumer Edge Research	Overweight
Jun-06-19	Initiated	Stifel	Hold
Jun-05-19	Initiated	Oppenheimer	Perform
May-15-19	Upgrade	BMO Capital Markets	Underperform → Market Perform
May-13-19	Initiated	Alliance Global Partners	Neutral

View All

Tilray Brands Inc Stock (TLRY) Latest News

Where Will Tilray Stock Be in 1 Year?

The Motley Fool

Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World

GlobeNewswire Inc.

Cannabis Companies' Gains - U.S. Versus Canada: Averages Can Be Deceiving, Irrational Market Behavior To Blame?

Benzinga

Sweetwater Brewing Unveils Modern Rebrand

GlobeNewswire Inc.

3 Reasons Tilray Brands Investors Shouldn't Assume U.S. Marijuana Legalization Would Fix the Stock's Problems

The Motley Fool

Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation

GlobeNewswire Inc.

Tilray Brands Inc Stock (TLRY) Financials Data

Tilray Brands Inc (TLRY) Revenue 2024

TLRY reported a revenue (TTM) of $743.25 million for the quarter ending February 29, 2024, a +24.65% rise year-over-year.

Tilray Brands Inc (TLRY) Net Income 2024

TLRY net income (TTM) was -$351.95 million for the quarter ending February 29, 2024, a +80.36% increase year-over-year.

Tilray Brands Inc (TLRY) Cash Flow 2024

TLRY recorded a free cash flow (TTM) of -$49.96 million for the quarter ending February 29, 2024, a +28.84% increase year-over-year.

Tilray Brands Inc (TLRY) Earnings per Share 2024

TLRY earnings per share (TTM) was -$0.44 for the quarter ending February 29, 2024, a +85.53% growth year-over-year.

Tilray Brands Inc Stock (TLRY) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Gendel Mitchell	Global General Counsel	Jan 16 '24	Buy	1.98	7,200	14,256	195,796
SIMON IRWIN D	President and CEO	Jan 12 '24	Buy	1.88	53,700	100,956	2,033,058
Merton Carl A	Chief Financial Officer	Jan 12 '24	Buy	1.87	20,000	37,400	20,000
Gendel Mitchell	Global General Counsel	Jan 12 '24	Buy	1.87	5,400	10,098	188,596
SIMON IRWIN D	President and CEO	Jul 31 '23	Option Exercise	2.53	1,412,428	3,573,443	2,760,452
Gendel Mitchell	Global General Counsel	Jul 31 '23	Option Exercise	2.53	187,852	475,266	279,095
FALTISCHEK DENISE M	Chief Strategy Officer	Jul 31 '23	Option Exercise	2.53	187,852	475,266	379,168
Merton Carl A	Chief Financial Officer	Jul 31 '23	Option Exercise	2.53	187,852	475,266	524,552
SIMON IRWIN D	President and CEO	Jul 27 '23	Option Exercise	2.14	98,192	210,131	1,402,326
SIMON IRWIN D	President and CEO	Jul 26 '23	Option Exercise	1.93	94,891	183,140	1,356,609

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.